Vaishali Pharma [VAISHALI] vs Aarey Drugs [AAREYDRUGS] Detailed Stock Comparison

Vaishali Pharma Ltd.

NSE
Loading...

Aarey Drugs & Pharmaceuticals Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Vaishali Pharma Ltd. wins in 5 metrics, Aarey Drugs & Pharmaceuticals Ltd. wins in 12 metrics, with 0 ties. Aarey Drugs & Pharmaceuticals Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Vaishali Pharma Ltd. Aarey Drugs & Pharmaceuticals Ltd. Better
P/E Ratio (TTM) 133.83 72.40 Aarey Drugs & Pharmaceuticals Ltd.
Price-to-Book Ratio 1.57 1.66 Vaishali Pharma Ltd.
Debt-to-Equity Ratio 23.15 38.27 Vaishali Pharma Ltd.
PEG Ratio N/A -3.14 N/A
EV/EBITDA -60.31 119.92 Aarey Drugs & Pharmaceuticals Ltd.
Profit Margin (TTM) -0.45% 0.88% Aarey Drugs & Pharmaceuticals Ltd.
Operating Margin (TTM) 5.81% -2.43% Vaishali Pharma Ltd.
EBITDA Margin (TTM) 5.81% N/A N/A
Return on Equity 1.26% 2.91% Aarey Drugs & Pharmaceuticals Ltd.
Return on Assets (TTM) 0.74% 1.39% Aarey Drugs & Pharmaceuticals Ltd.
Free Cash Flow (TTM) $-183.43M $50.96M Aarey Drugs & Pharmaceuticals Ltd.
1-Year Return -44.99% 40.83% Aarey Drugs & Pharmaceuticals Ltd.
Price-to-Sales Ratio (TTM) 0.92 0.64 Aarey Drugs & Pharmaceuticals Ltd.
Enterprise Value $1.24B $3.00B Aarey Drugs & Pharmaceuticals Ltd.
EV/Revenue Ratio 1.09 0.77 Aarey Drugs & Pharmaceuticals Ltd.
Gross Profit Margin (TTM) 1.47% -0.38% Vaishali Pharma Ltd.
Revenue per Share (TTM) $10 $137 Aarey Drugs & Pharmaceuticals Ltd.
Earnings per Share (Diluted) $0.06 $1.22 Aarey Drugs & Pharmaceuticals Ltd.
Beta (Stock Volatility) -0.01 0.80 Vaishali Pharma Ltd.

Vaishali Pharma Ltd. vs Aarey Drugs & Pharmaceuticals Ltd. Stock Performance Analysis

Loading Price Chart...

VAISHALI
AAREYDRUGS

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Vaishali Pharma Ltd.0.42%-1.78%2.43%19.70%-10.93%-16.04%
Aarey Drugs & Pharmaceuticals Ltd.1.93%-0.70%-10.54%26.33%21.44%17.47%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Vaishali Pharma Ltd.-44.99%-44.04%83.08%68.79%68.79%68.79%
Aarey Drugs & Pharmaceuticals Ltd.40.83%131.70%79.58%79.58%79.58%79.58%

Performance & Financial Health Analysis: Vaishali Pharma Ltd. vs Aarey Drugs & Pharmaceuticals Ltd.

MetricVAISHALIAAREYDRUGS
Market Information
Market Cap i₹1.05B₹2.50B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i871,885287,283
90 Day Avg. Volume i455,768157,618
Last Close₹7.17₹79.35
52 Week Range₹4.75 - ₹13.59₹50.31 - ₹100.00
% from 52W High-47.24%-20.65%
All-Time High₹24.91 (Oct 14, 2024)₹100.00 (Nov 06, 2025)
% from All-Time High-71.22%-20.65%
Growth Metrics
Quarterly Revenue Growth-0.12%-0.28%
Quarterly Earnings Growth-0.09%-0.21%
Financial Health
Profit Margin (TTM) i0.00%0.01%
Operating Margin (TTM) i0.06%-0.02%
Return on Equity (TTM) i0.01%0.03%
Debt to Equity (MRQ) i23.1538.27
Cash & Liquidity
Book Value per Share (MRQ)₹5.11₹53.06
Cash per Share (MRQ)₹0.08₹2.88
Operating Cash Flow (TTM) i₹-326,443,000₹366.06M
Levered Free Cash Flow (TTM) i₹8.17M₹40.24M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Vaishali Pharma Ltd. vs Aarey Drugs & Pharmaceuticals Ltd.

MetricVAISHALI (Apr 26, 2026)AAREYDRUGS (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i133.8372.40
Forward P/E iN/AN/A
PEG Ratio iN/A-3.14
Price to Sales (TTM) i0.920.64
Price to Book (MRQ) i1.571.66
Market Capitalization
Market Capitalization i₹1.05B₹2.50B
Enterprise Value i₹1.24B₹3.00B
Enterprise Value Metrics
Enterprise to Revenue i1.090.77
Enterprise to EBITDA i-60.31119.92
Risk & Other Metrics
Beta i-0.010.80
Book Value per Share (MRQ) i₹5.11₹53.06

Financial Statements Comparison: Vaishali Pharma Ltd. vs Aarey Drugs & Pharmaceuticals Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricVAISHALI (2025)AAREYDRUGS (2025)
Revenue/Sales i978.82M4.72B
Cost of Goods Sold i856.75M4.62B
COGS % of Revenue i87.5%97.8%
Gross Profit i122.07M101.74M
Gross Margin i12.5%2.2%
Research & Development iN/AN/A
Operating Income (EBIT) i59.00M8.08M
Operating Margin i6.0%0.2%
EBITDA i93.22M119.28M
EBITDA Margin i9.5%2.5%
Pre-Tax Income i12.26M61.02M
Pre-Tax Income % of Revenue i1.3%1.3%
Income Tax i4.08M20.78M
Income Tax % of Revenue i0.4%0.4%
Net Income (Profit) i8.17M40.24M
Profit Margin i0.8%0.9%

Balance Sheet & Liquidity Metrics

MetricVAISHALI (2025)AAREYDRUGS (2025)
Cash & Equivalents i17.11M14.73M
Total Current Assets i1.04B2.66B
Total Current Assets % of Revenue i106.7%56.2%
Total Current Liabilities i400.53M1.49B
Total Current Liabilities % of Revenue i40.9%31.6%
Long-Term Debt i46.19M19.87M
Long-Term Debt % of Revenue i4.7%0.4%
Total Shareholders Equity i649.16M1.38B
Retained Earnings i157.29M571.32M
Retained Earnings % of Revenue i16.1%12.1%
Property, Plant & Equipment i01.96M

Cash Flow Statement Comparison

MetricVAISHALI (2025)AAREYDRUGS (2025)
Operating Cash Flow i-326.44M366.06M
Operating Cash Flow % of Revenue i-33.4%7.8%
Capital Expenditures i-3.05M-52.04M
Free Cash Flow i-183.43M50.96M
FCF Margin i-18.7%1.1%
Debt Repayment iN/A-15.08M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricVAISHALIAAREYDRUGS
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i130.46M28.35M
Float Shares i68.14M13.23M
% Held by Insiders iN/A51.04%
% Held by Institutions iN/A1.06%
% Held by Public iN/A47.90%

Dividend Analysis & Yield Comparison: Vaishali Pharma Ltd. vs Aarey Drugs & Pharmaceuticals Ltd.

MetricVAISHALIAAREYDRUGS
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A